Cargando…

Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease

Despite its association with adverse outcomes, peripheral artery disease (PAD) remains undertreated. Cystatin C is elevated in patients with renal disease and may be a marker of cardiovascular disease. We examined the prognostic ability of urinary Cystatin C (uCystatinC) in predicting adverse PAD-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ben, Zamzam, Abdelrahman, Syed, Muzammil H., Jahanpour, Niousha, Jain, Shubha, Abdin, Rawand, Qadura, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313414/ https://www.ncbi.nlm.nih.gov/pubmed/35883416 http://dx.doi.org/10.3390/biom12070860

Ejemplares similares

Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

The Clinical Utility of D-Dimer and Prothrombin Fragment (F1+2) for Peripheral Artery Disease: A Prospective Study
por: Arfan, Sara, et al.
Publicado: (2022)

Angiogenesis-related proteins as biomarkers for peripheral artery disease
por: Li, Ben, et al.
Publicado: (2023)

The prognostic capability of inflammatory proteins in predicting peripheral artery disease related adverse events
por: Li, Ben, et al.
Publicado: (2022)

Urinary neutrophil gelatinase-associated lipocalin (NGAL) can potentially predict vascular complications and reliably risk stratify patients with peripheral arterial disease
por: Ehsan, Mehroz, et al.
Publicado: (2022)

Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease
por: Zamzam, Abdelrahman, et al.
Publicado: (2021)

Plasma complement component C2: a potential biomarker for predicting abdominal aortic aneurysm related complications
por: Feridooni, Tiam, et al.
Publicado: (2022)

Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease
por: Azab, Sandi M., et al.
Publicado: (2020)

MicroRNA Profile of Patients with Chronic Limb-Threatening Ischemia
por: Syed, Muzammil H., et al.
Publicado: (2020)

Fatty Acid Binding Protein 4—A Circulating Protein Associated with Peripheral Arterial Disease in Diabetic Patients
por: Zamzam, Abdelrahman, et al.
Publicado: (2020)

Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: A three-year prospective follow-up study
por: Zamzam, Abdelrahman, et al.
Publicado: (2022)

Fatty acid binding protein 3 is associated with peripheral arterial disease
por: Syed, Muzammil H., et al.
Publicado: (2020)

Plateletworks(®) as a Point-of-Care Test for ASA Non-Sensitivity
por: Khan, Hamzah, et al.
Publicado: (2021)

Perceived Challenges to Routine Uptake of the Ankle Brachial Index within Primary Care Practice
por: Chiu, Lily Y. C., et al.
Publicado: (2021)

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease
por: Alsuwailem, Bader, et al.
Publicado: (2021)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
por: Khan, Hamzah, et al.
Publicado: (2022)

Increasing Awareness for Peripheral Artery Disease through the Identification of Novel Biomarkers
por: Li, Ben, et al.
Publicado: (2023)

A Systematic Review of Interleukins as Diagnostic and Prognostic Biomarkers for Peripheral Artery Disease
por: Djahanpour, Niousha, et al.
Publicado: (2023)

Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry
por: Khan, Hamzah, et al.
Publicado: (2020)

Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
por: Khan, Hamzah, et al.
Publicado: (2021)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
por: Khan, Hamzah, et al.
Publicado: (2020)

The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases
por: Li, Ben, et al.
Publicado: (2022)

Valproic Acid Induces Endothelial-to-Mesenchymal Transition-Like Phenotypic Switching
por: Murugavel, Shamini, et al.
Publicado: (2018)

Current Biomarkers for Carotid Artery Stenosis: A Comprehensive Review of the Literature
por: Khan, Hamzah, et al.
Publicado: (2023)

Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy
por: Khan, Hamzah, et al.
Publicado: (2022)

Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
por: Chen, Ye-yang, et al.
Publicado: (2023)

Management of a Mycotic Aneurysm in a Patient with COVID-19: A Case Report
por: Syed, Muzammil H., et al.
Publicado: (2021)

Elevated Serum Cystatin C and Decreased Cathepsin S/Cystatin C Ratio Are Associated with Severe Peripheral Arterial Disease and Polyvascular Involvement
por: Nagy, Előd Ernő, et al.
Publicado: (2022)

Prognostic value of serum cystatin C concentration in dogs with myxomatous mitral valve disease
por: Iwasa, Naoki, et al.
Publicado: (2023)

Discrepant changes of urinary cystatin C and other urinary biomarkers in preterm neonates()
por: Filler, Guido, et al.
Publicado: (2021)

Prognostic value of cystatin C in patients with nasopharyngeal carcinoma: a retrospective study of 1063 patients
por: Yuan, Jing, et al.
Publicado: (2016)

β2‐Microglobulin, Cystatin C, and Creatinine and Risk of Symptomatic Peripheral Artery Disease
por: Joosten, Michel M., et al.
Publicado: (2014)

Prognostic value of preoperative serum cystatin-C level for non-metastatic renal cell carcinoma—correspondence
por: Tang, Yaxiong, et al.
Publicado: (2023)

Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy
por: Kim, Sang Soo, et al.
Publicado: (2013)

Cystatin C Has a Dual Role in Post-Traumatic Brain Injury Recovery
por: Martinez-Vargas, Marina, et al.
Publicado: (2014)

The Predictability of Cystatin C for Peripheral Arterial Disease in Chinese Population with Type 2 Diabetes Mellitus
por: Liu, Luna, et al.
Publicado: (2022)

Prognostic Value of Pretreatment Serum Cystatin C Level in Nasopharyngeal Carcinoma Patients in the Intensity-modulated Radiotherapy Era
por: Tan, Xi-Rong, et al.
Publicado: (2021)

Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
por: Shi, Shanshan, et al.
Publicado: (2022)

Prognostic value of creatinine-to-cystatin c ratio in patients with type 2 diabetes mellitus: a cohort study
por: Wei, Wen, et al.
Publicado: (2022)

Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early-stage pancreatic ductal adenocarcinoma
por: Yang, Chengkun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1eamqlkdr8s02enoajq12k7l9k